| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.92T | 2.89T | 2.73T | 2.41T | 1.98T | 1.76T |
| Gross Profit | 1.04T | 1.03T | 964.48B | 636.22B | 299.43B | -40.26B |
| EBITDA | 773.85B | 778.32B | 748.45B | 541.16B | 249.97B | -120.36B |
| Net Income | 229.68B | 224.28B | 196.45B | 99.23B | -94.95B | -577.90B |
Balance Sheet | ||||||
| Total Assets | 10.10T | 10.17T | 9.77T | 9.41T | 9.16T | 8.98T |
| Cash, Cash Equivalents and Short-Term Investments | 184.76B | 233.67B | 281.00B | 215.19B | 171.29B | 198.27B |
| Total Debt | 4.63T | 4.65T | 4.56T | 4.46T | 4.05T | 3.61T |
| Total Liabilities | 7.18T | 7.30T | 7.03T | 6.91T | 6.74T | 6.42T |
| Stockholders Equity | 2.90T | 2.86T | 2.72T | 2.47T | 2.39T | 2.54T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -38.68B | -26.81B | 26.17B | -392.55B | -955.45B |
| Operating Cash Flow | 0.00 | 732.25B | 688.10B | 581.75B | 190.51B | -189.97B |
| Investing Cash Flow | 0.00 | -783.42B | -690.62B | -565.51B | -526.36B | -749.40B |
| Financing Cash Flow | 0.00 | 3.66B | 66.10B | 26.83B | 304.64B | 983.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $84.47B | 23.65 | 23.52% | 1.42% | -0.92% | -2.64% | |
71 Outperform | $24.29B | 15.79 | 7.72% | 1.30% | 6.34% | 2.27% | |
70 Outperform | $71.62B | 29.53 | 17.43% | 1.85% | 0.60% | -19.01% | |
68 Neutral | $23.14B | 6.60 | 20.95% | 0.74% | -1.74% | 95.97% | |
65 Neutral | $159.66B | 21.15 | 41.95% | 2.32% | 1.87% | 9.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $18.67B | 20.61 | 10.67% | 1.73% | 4.72% | 72.71% |